TITLE

Renin-Angiotensin System Blockade Is Associated With the Long-Term Protection Against Cardiac Remodeling with the Cardioversion in Hypertensive Patients with Atrial Fibrillation

AUTHOR(S)
Egami, Yasuyuki; Nishino, Masami; Taniike, Masayuki; Makino, Nobuhiko; Kato, Hiroyasu; Shutta, Ryu; Yamaguchi, Hitoshi; Tanouchi, Jun; Yamada, Yoshio
PUB. DATE
July 2010
SOURCE
Tohoku Journal of Experimental Medicine;Jul2010, Vol. 221 Issue 3, p251
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Atrial fibrillation (AF) is the most common arrhythmia, and renin-angiotensin system blockade (RAS-B) may be favorable for AF because of its effect on cardiac remodeling. However, effects of RAS-B on AF in hypertensive patients are controversial. Thus, in this study, we investigated the long-term effects of RAS-B on cardiac remodeling and rhythm control after electrical cardioversion for hypertensive patients with persistent AF. We studied 27 consecutive hypertensive patients with persistent AF (duration > one week) who received electrical cardioversion and once recovered to sinus rhythm. Blood pressure of the patients was controlled by medication including RAS-B. The patients were divided into those who were pre-treated with RAS-B (n = 10) for at least two months before electrical cardioversion and those without RAS-B (n = 17). We performed echocardiography before electrical cardioversion and 3 years after electrical cardioversion in all patients and compared the differences in echocardiographic cardiac remodeling parameters, including left atrial dimension, left ventricular end-diastolic dimension and left ventricular ejection fraction. The AF recurrence-free ratio during the follow-up period was significantly higher in the RAS-B group than in the non-RAS-B group, judged by Kaplan-Meier analysis (60 vs. 24%, P = 0.01). All cardiac remodeling parameters in the RAS-B group showed better values than those in non-RAS-B group (each parameter, P < 0.05), supporting the beneficial effects of RAS-B on AF in hypertensive patients. In hypertensive patients with AF, pre-treatment with RAS-B before electrical cardioversion can prevent cardiac remodeling for 3 years and maintain sinus rhythm.
ACCESSION #
52918022

 

Related Articles

  • Effects of Renin–Angiotensin System Inhibition on Left Atrial Function of Hypertensive Patients: An Echocardiographic Tissue Deformation Imaging Study. Dimitroula, Hariklia; Damvopoulou, Efthalia; Giannakoulas, Georgios; Dalamanga, Emmanouella; Dimitroulas, Theodoros; Sarafidis, Pantelis A.; Styliadis, Haralambos; Hatzitolios, Apostolos; Karvounis, Haralambos; Parcharidis, Georgios // American Journal of Hypertension;May2010, Vol. 23 Issue 5, p556 

    BackgroundAlthough renin–angiotensin system (RAS) inhibitors have beneficial effects on left ventricular myocardium, their effect on left atrial (LA) function remains unknown. The aim of this study was to evaluate the effect of treatment with RAS inhibitors on LA function of patients with...

  • A hand in the heart. Shah, Benoy Nalin; Senior, Roxy // Heart;Mar2012, Vol. 98 Issue 6, p520 

    The article presents a case study of a 58-year-old man with hypertension who was admitted to the hospital for showing severe dyspnoea symptoms. His electrocardiography reports revealed atrial fibrillation. He was recommended for transoesophageal echocardiography (TOE) for examining left atrial...

  • Single High Oral Dose Amiodarone for Cardioversion of Recent Onset Atrial Fibrillation Nadarasa, Kugathasan; Williams, Michael J.A. // Heart, Lung & Circulation;Aug2012, Vol. 21 Issue 8, p444 

    Background: Selection of a pharmacological agent and mode of administration for cardioversion is a challenging task in recent onset atrial fibrillation. Aim: To report our experience using single high dose oral amiodarone for the cardioversion of recent onset atrial fibrillation to sinus rhythm...

  • Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation. Hirt, Liam S.; Gobin, Maya S. // Cardiology Research;2012, Vol. 3 Issue 4, p158 

    Background: Direct current cardioversion (DCCV) can restore sinus rhythm in patients with atrial fibrillation (AF), but the long term efficacy is poor. Pharmacological therapies may improve the initial success of the procedure, but whether long term maintenance of sinus rhythm can be improved is...

  • The Role Of Renin Angiotensin System In Atrial Fibrillation. Nair, Girish M.; Nery, Pablo B.; Redpath, Calum J.; Birnie, David H. // JAFIB: Journal of Atrial Fibrillation;Apr/May2014, Vol. 6 Issue 6, p91 

    Atrial fibrillation (AF) is the most prevalent arrhythmia and its incidence is on the rise. AF causes significant morbidity and mortality leading to rising AF-related health care costs. There is experimental and clinical evidence from animal and human studies that suggests a role for the renin...

  • Mitral annular velocity by Doppler tissue imaging for the evaluation of atrial stunning after cardioversion of atrial fibrillation. Omer Gedikli; Mehmet Ozaydin; Gurkan Acar; Alaettin Avsar; Ahmet Altinbas // International Journal of Cardiovascular Imaging;Feb2009, Vol. 25 Issue 2, p113 

    Abstract   Objective Atrial and/or appendage stunning (AS) usually occur after successful cardioversion of atrial fibrillation (AF). Several parameters except mitral annular velocity were previously evaluated to determine AS. We investigated whether mitral annular velocity was useful for...

  • Management in general practice of hypertensive patients poorly controlled with a fixed-dose renin�angiotensin system inhibitor and diuretic combination: results from a French national survey. Ragot, S.; Sosner, P.; Yau, C.; Brunel, P.; Herpin, D. // Journal of Human Hypertension;Jun2006, Vol. 20 Issue 6, p407 

    High rates of uncontrolled hypertensives have been reported in France as well as in other countries, partly owing to an inadequate management of hypertension by clinicians. The objectives of the study were (1) to describe the therapeutic decisions faced by general practitioners (GP) in...

  • Blood Pressure Management in Metabolic Syndrome. Yano, Yuichiro; Hoshide, Satoshi; Shimada, Kazuyuki; Kario, Kazuomi // Current Hypertension Reviews;2008, Vol. 4 Issue 3, p214 

    To assess 24-hour BP levels in subjects with metabolic syndrome is essential, because hypertension, which is the most prevalent component in the syndrome, makes the major contribution to cardiovascular risk. Because BP levels in subjects with metabolic syndrome are prone to be elevated in an...

  • BASIC PRINCIPLES OF EFFECTIVE HYPERTENSION THERAPEUTICS. Flack, John M. // Ethnicity & Disease;Autumn2009, Vol. 19 Issue 4, pS51 

    The article focuses on effective treatment for hypertension. It cites the importance of accurate measurement of blood pressure (BP) level for the treatment of hypertension. It notes that there is no significant difference in BP response to renin angiotensin system (RAS) antagonists when mixed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics